These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9779650

  • 1. Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain.
    Jiang F, Lilge L, Belcuig M, Singh G, Grenier J, Li Y, Chopp M.
    Lasers Surg Med; 1998; 23(3):161-6. PubMed ID: 9779650
    [Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy with photofrin in combination with Buthionine Sulfoximine (BSO) of human glioma in the nude rat.
    Jiang F, Robin AM, Katakowski M, Tong L, Espiritu M, Singh G, Chopp M.
    Lasers Med Sci; 2003; 18(3):128-33. PubMed ID: 14505195
    [Abstract] [Full Text] [Related]

  • 3. Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin.
    Jiang F, Lilge L, Logie B, Li Y, Chopp M.
    Photochem Photobiol; 1997 Apr; 65(4):701-6. PubMed ID: 9114747
    [Abstract] [Full Text] [Related]

  • 4. L-buthionine sulfoximine potentiates the antitumor effect of 4-hydroperoxycyclophosphamide when administered locally in a rat glioma model.
    Sipos EP, Witham TF, Ratan R, Burger PC, Baraban J, Li KW, Piantadosi S, Brem H.
    Neurosurgery; 2001 Feb; 48(2):392-400. PubMed ID: 11220384
    [Abstract] [Full Text] [Related]

  • 5. Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat.
    Zhang X, Jiang F, Kalkanis SN, Yang H, Zhang Z, Katakowski M, Hong X, Zheng X, Chopp M.
    Photochem Photobiol; 2006 Feb; 82(6):1704-11. PubMed ID: 17007560
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of 9L gliosarcomas to photodynamic therapy.
    Chopp M, Dereski MO, Madigan L, Jiang F, Logie B.
    Radiat Res; 1996 Oct; 146(4):461-5. PubMed ID: 8927718
    [Abstract] [Full Text] [Related]

  • 7. Post-acute response of 9L gliosarcoma to Photofrin-mediated PDT in athymic nude mice.
    Zhang X, Jiang F, Kalkanis SN, Zhang Z, Hong X, Yang H, Chopp M.
    Lasers Med Sci; 2007 Nov; 22(4):253-9. PubMed ID: 17505777
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin.
    Jiang F, Lilge L, Grenier J, Li Y, Wilson MD, Chopp M.
    Lasers Surg Med; 1998 Nov; 22(2):74-80. PubMed ID: 9484699
    [Abstract] [Full Text] [Related]

  • 9. Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells.
    Lee HM, Kim DH, Lee HL, Cha B, Kang DH, Jeong YI.
    Arch Pharm Res; 2019 Nov; 42(11):990-999. PubMed ID: 31482490
    [Abstract] [Full Text] [Related]

  • 10. Atorvastatin reduces functional deficits caused by photodynamic therapy in rats.
    Zheng X, Chopp M, Lu Y, Jiang J, Zhao D, Ding C, Yang H, Zhang L, Jiang F.
    Int J Oncol; 2011 Nov; 39(5):1133-41. PubMed ID: 21850369
    [Abstract] [Full Text] [Related]

  • 11. Experimental research photodynamic effects in perifocal, oedematous brain tissue.
    Goetz C, Hasan A, Stummer W, Heimann A, Kempski O.
    Acta Neurochir (Wien); 2002 Feb; 144(2):173-9; discussion 179. PubMed ID: 11862518
    [Abstract] [Full Text] [Related]

  • 12. Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
    Anderson CP, Matthay KK, Perentesis JP, Neglia JP, Bailey HH, Villablanca JG, Groshen S, Hasenauer B, Maris JM, Seeger RC, Reynolds CP.
    Pediatr Blood Cancer; 2015 Oct; 62(10):1739-46. PubMed ID: 26153194
    [Abstract] [Full Text] [Related]

  • 13. Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin.
    Uehara M, Inokuchi T, Ikeda H.
    J Oral Maxillofac Surg; 2006 Mar; 64(3):390-6. PubMed ID: 16487799
    [Abstract] [Full Text] [Related]

  • 14. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
    Xiao Z, Brown K, Tulip J, Moore RB.
    J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
    [Abstract] [Full Text] [Related]

  • 15. Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.
    Bailey HH, Ripple G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Mahvi D, Schink J, Pomplun M, Mulcahy RT, Wilding G.
    J Natl Cancer Inst; 1997 Dec 03; 89(23):1789-96. PubMed ID: 9392620
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
    O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF.
    J Clin Oncol; 1996 Jan 03; 14(1):249-56. PubMed ID: 8558205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.